As Head of MSci Innovation, I spearhead GMS Manufacturing Technology Strategy Tier 4/5 initiative for FY22 by conceptualising and streamlining strategic process. I am responsible for managing global initiative in partnering with a consulting company for long-term strategy development of 20 local Manufacturing Sciences (MSci) laboratories, whilst driving innovation, lab efficiency, and accelerated tech transfer. Key Contributions: • Enhanced overall agility in decision-making, minimised implementation time, and elevated 5% efficiency in target of GMS and performance by tracking, selecting, and prioritising manufacturing.• Governed devising and implementation of first-ever centralised technology ideation and prioritisation tool, BrightIdea, whilst enabling cross-collaboration and harmonisation through Manufacturing Technology Forum; • Engaged with senior and executive leadership regularly for assisting in driving developments of manufacturing technology capability assessment and improvement opportunities across Takeda's GMS network.• Influenced on global manufacturing community through global world cafe discussions with comprehensive competitive intelligence analysis supporting in identifying key trends and opportunities in industry with detailed financial peer review, SWOT analysis, and COVID-19 impact analysis for improvement areas.• Represented Takeda as Co-chair of ISPE Pharma 4.0, Plug & Produce developing industry roadmap for next decade.• Directed transformational proof of concepts and introduced new ways of working through Pharma hackathons for innovation in pharmaceutical industry. • Developed within six months a Global Manufacturing Science LabStrategy through design sprints encompassing 20 local MSci labs including road-map and a 3-5 years budget with the objective of achieving a 30 % cost reduction. • Integrated annual business intelligence for driving innovation, new technology, and delivered Takeda competitive advantage in manufacturing.

During this tenure, I have led establishment of global technology and automation team within Takeda to facilitate seamless integration of engineering and automation solutions worldwide. I was liable for actively participating in pilots, partner workshops, international conferences, and events, whilst orchestrating technology scouting and driving industrial development.Key Contributions: • Oversaw roll-out of Global IT and Automation community (GIAC) for nurturing strong collaboration between automation team and global IT departments. • Acted in double management function, successfully building and leading regional engineering organisation. • Led regional CAPEX investments and oversaw technical improvements for 10 production sites within Europe/CIS, including one API plant in India.• Conducted due diligence and provided support initiating CAPEX investments.• Supported internal customers, including regional/functional heads, leadership teams, and sites, by leveraging efficient, effective, and innovative technology.• Established standards for site production, fostering knowledge sharing, and promoting standardised practices. • Directed incorporation of cutting-edge technology platform, UPI (Track & Trace) program fulfilling urgent regulatory requirements, whilst ensuring uninterrupted productivity in compliance with global standards. • Employed latest industry KPIs to Takeda and provided framework for manufacturing and digitalisation. • Devised and executed robust automation strategy for FY16-19 and introduced pioneering automation guidelines for revolutionisation of Takeda's approach to automation, entailing;o Lupron Manufacturing Facility - Fully robotised filling line.o Alofisel Stem Cell Production - Introduced turnkey modular design and construction, Automation Concept & MES, Cobots/Robots.o TaSiVa Vaccine Facility - Introduce first in industry automation layer and industry grade protocols.

Whilst serving as Global Technology Manager, I have advised CEO of company as well as delivered expert guidelines and strategic insights on pharmaceutical and life sciences modalities. Furthermore, I have leveraged technical expertise to drive advancements in facility delivery and sustainability within Life Science, Pharmaceutical, and Medical Device sector as per thorough analysis of industry trends.Key Contributions:• Initiated new business unit with keen emphasis on life sciences and drove expansion to company's capabilities throughout industry in coordination with external consultants from BCG.• Played pivotal role as GMP consultant to offer valuable support and front-end engineering expertise for Biotech, Fill & Finish, OSD, New vaccine production facility (with project volume of 120 Mio €), and Medical Device clients.• Provided leadership expertise as Project and Construction Manager for process and clean services, while governing "turn-key and large-scale facilities" projects in adherence to strict timelines and budgets (projects with a volume of up to 250 Mio €).